Healthcare >> Sector Roundtables >> December 13, 1999
RICHARD B. SILVER is a Senior Vice President and Senior Research Analyst
at Lehman Brothers, where he is a member of the healthcare equity
research team. Mr. Silver focuses on specialty and niche
pharmaceuticals, drug delivery technology and generic drugs. Prior to
joining Lehman Brothers he was with Chase Manhattan Bank as a Credit
Analyst. Mr. Silver hold a BA from the University of Connecticut. Profile
JERRY TREPPEL is a Managing Director with Banc of America Securities
LLC. He holds a Bachelor's degree in Microbiology from Rutgers
University, a Master's degree in Hospital Administration from Washington
University, and an M.B.A. from New York University. Mr. Treppel was
previously associated with Warburg Dillon Read, Dillon Read, and Furman
Celz. His interests include politics, Judaic history, and baseball. Profile
IAN C. SANDERSON is a Managing Director at SG Cowen. A member of the
Healthcare/ Pharmaceutical Team, he covers emerging and mid cap
pharmaceutical companies including specialty pharmaceutical, drug
delivery and generic pharmaceutical companies. Prior to joining SG
Cowen, Mr. Sanderson was associated with Houlihan Lokey Howard & Zukin,
Cambridge Associates and Putnam International Advisors and U.S. Surgical
Corporation. He received a BA in Political Economy from Williams College
and an MBA in Finance from the Wharton School at the University of
Pennsylvania. Profile
ALEX ZISSON is a Managing Director and Senior Pharmaceutical Analyst
with Chase H&Q. He earned his Bachelor's degree from Brown University.
In his leisure, Mr. Zisson enjoys 'thinking about ways to make his
clients money' and playing bridge. Profile
pharmaceuticals and drug delivery companies over the past 12 months. How
have these stocks performed year-to-date?
Mr.
